Status:
COMPLETED
Prevention of Neurosurgical Wound Infections
Lead Sponsor:
Oregon Health and Science University
Conditions:
Surgical Wound Infections
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.
Eligibility Criteria
Inclusion
- deep brain stimulators (DBS)
- spinal cord stimulators (SCS)
- motor cortex stimulators (MCS)
- vagus nerve stimulators (VNS)
- peripheral nerve stimulators (PNS)
Exclusion
- allergies to vancomycin
- immunocompromise or taking immunosuppressant drugs
- currently taking aminoglycoside antibiotics, such as amikacin, gentamicin, neomycin, streptomycin or tobramycin
- diagnosed renal failure
- currently undergoing chemotherapy
- pregnancy
- non-english speakers
- unable to return for follow-up, or unable to be contacted by telephone
Key Trial Info
Start Date :
May 13 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2014
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT00915967
Start Date
May 13 2009
End Date
December 19 2014
Last Update
April 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Oregon Health & Science University
Portland, Oregon, United States, 97239